Clinical Trial Update: Efficacy and Safety of HemoStyp as an Adjunct for Management of Secondary Hemostasis in the Operative Setting [NA]

View source ↗

Summary

A completed clinical trial evaluating HemoStyp as an adjunct to manage secondary hemostasis during surgery, with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bleeding Disorders
• Hemostasis Disorders

Drugs mentioned

• HemoStyp (null)

Snippet

Sponsor: United Health Products, Inc. | Conditions: Hemostasis, Bleeding | NA | Status: COMPLETED | Results posted: 2020-10-22